At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study: Topical Application of Medihoney for Management of Radiation Dermatitis
In Brief
A clinical study evaluating Hydrophor (Group A) and MediHoney (Group B) for Breast Cancer and Radiation Dermatitis. Completed, enrolled 34 participants across 1 site.
Detailed Summary
The aim of this study is to compare the effects of Medihoney and Hydrophor on radiation dermatitis reactions in a group of women undergoing radiation therapy for breast cancer. It is hoped that the outcome of this pilot study will provide evidence supporting the use of Medihoney in preventing and treating radiation dermatitis as well as sufficient preliminary data to expand this study to larger, federally funded research (R01) looking at the beneficial aspects of Medihoney across a spectrum of radiation dermatitis and mucositis in several disease settings.
Study Details
Timeline
Interventions
* Rehydrates dry, chapped or chafed skin * May be used alone as a skin lubricant or protectant
It helps the body's natural healing processes in three key ways which have been shown to have healing benefits: * Maintain a balanced environment for healing. * Aids in reducing dermatitis. * Reduce affected area pH.2-3